{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-117200","form_type":"8-K","ticker":"VSEE","cik":"0001864531","company_name":"VSEE HEALTH, INC.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.180524+00:00","generated_at":"2026-06-08T05:35:20.591476+00:00","sec_items":["1.01","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Digital Health Acquisition Corp. extends business combination deadline to Nov 8, 2024; 579,157 shares redeemed","bullets":["Stockholders approved extension of business combination deadline from Nov 8, 2023 up to four 3-month extensions to Nov 8, 2024.","579,157 shares were tendered for redemption in connection with the extension vote, reducing trust assets.","Company immediately executed first three-month extension to Feb 8, 2024.","Stockholders also approved charter amendment permitting stockholder action by written consent.","Five directors re-elected and WithumSmith+Brown ratified as auditor for FY 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-117200","json":"https://secwatch.observer/filing/0001104659-23-117200.json","markdown":"https://secwatch.observer/filing/0001104659-23-117200.md","text":"https://secwatch.observer/filing/0001104659-23-117200.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923117200/0001104659-23-117200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923117200/tm2330463d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T05:35:20.591476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01fc039d114398cabdd4f81dfa4f3b1d622b45d4","claim":"VSEE HEALTH, INC. amended Trust Amendment with Continental Stock Transfer & Trust Company (effective 2023-11-06).","evidence_excerpt":"Digital Health Acquisition Corp. (the “Company”) entered into an amendment (the “Trust Amendment”) to the investment management trust agreement, dated as of November 3, 2021, as amended on October 26, 2022, with Continental Stock Transfer & Trust Company on November 6, 2023.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923117200/0001104659-23-117200-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"Continental Stock Transfer & Trust Company"},{"label":"Effective","value":"2023-11-06"}],"fact_type":"material_agreement"},{"claim_id":"1c7ce855e7267f91338db0bb67a2276924a592b2","claim":"VSEE HEALTH, INC. shareholders approved Amendment of the Company's investment management trust agreement, dated as of November 3, 2021, and as amended on October 26, 2022, by and between the Company and Continental Stock Transfer & Trust Company to (i) allow the Company to extend the business combination period from November 8, 2023 to up at the 2023-11-06 meeting.","evidence_excerpt":"Proposal 2: Trust Amendment Proposal Amendment of the Company’s investment management trust agreement, dated as of November 3, 2021, and as amended on October 26, 2022, by and between the Company and Continental Stock Transfer & Trust Company to (i) allow the Company to extend the business combination period from November 8, 2023 to up to four (4) times, each by an additional three (3) months, for an aggregate of twelve (12) additional months up to November 8, 2024, and (ii) update certain defined terms in the Trust Agreement. Adoption of the amendment required approval by the affirmative vote of at least 65% of the Company’s outstanding common stock. The Trust Amendment Proposal was approved by a vote of stockholders as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 3,694,592 1,531 0 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923117200/0001104659-23-117200-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-06"}],"fact_type":"shareholder_vote"},{"claim_id":"ca616626b422f81e94313bc9144853c401458613","claim":"VSEE HEALTH, INC. shareholders approved Amendment of the Company's Certificate of Incorporation to extend the business combination period from November 8, 2023 up to four (4) times, each by an additional three (3) months, for an aggregate of twelve (12) additional months up to November 8, 2024, or such earlier date as determined by the Bo at the 2023-11-06 meeting.","evidence_excerpt":"Proposal 1: Charter Amendment Proposal Amendment of the Company’s Certificate of Incorporation to extend the business combination period from November 8, 2023 up to four (4) times, each by an additional three (3) months, for an aggregate of twelve (12) additional months up to November 8, 2024, or such earlier date as determined by the Board. Adoption of the amendment required approval by the affirmative vote of at least 65% of the Company’s outstanding common stock. The Charter Amendment Proposal was approved by a vote of stockholders as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 3,694,592 1,531 0 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923117200/0001104659-23-117200-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-06"}],"fact_type":"shareholder_vote"},{"claim_id":"cb4977639065c5f3bb0c367b3676281d1be0c550","claim":"VSEE HEALTH, INC. shareholders approved Election of five directors to serve for a one-year term ending as of the annual meeting in 2024 or until his successor is duly elected and qualified. at the 2023-11-06 meeting.","evidence_excerpt":"Proposal 4: Directors Proposal Election of five directors to serve for a one-year term ending as of the annual meeting in 2024 or until his successor is duly elected and qualified. Directors are elected by the affirmative vote of a plurality of the shares of the common stock present by virtual attendance or represented by proxy and entitled to vote at the Meeting. The Directors Proposal was approved by a vote of stockholders as follows: FOR WITHHOLD Scott Wolf 3,696,023 100 Kevin Loudermilk 3,696,023 100 Frank Ciufo 3,696,023 100 George McNellage 3,696,023 100 Scott Metzger 3,694,592 1,531","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923117200/0001104659-23-117200-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-06"}],"fact_type":"shareholder_vote"},{"claim_id":"ec0fb6fc67efae580c30e070884fe75663740cb4","claim":"VSEE HEALTH, INC. shareholders approved Ratification of the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-11-06 meeting.","evidence_excerpt":"Proposal 5: Auditor Proposal Ratification of the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Ratification required the affirmative vote of holders of the majority of the outstanding shares represented by virtual attendance or by proxy and entitled to vote thereon at the Meeting. The ratification was approved a vote of stockholders as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 3,696,023 100 0 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923117200/0001104659-23-117200-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-06"}],"fact_type":"shareholder_vote"},{"claim_id":"f951ce58404580db25464ad25fc124aca3ffa040","claim":"VSEE HEALTH, INC. shareholders approved Amendment of the Company's Certificate of Incorporation to allow stockholders to act by written consent. at the 2023-11-06 meeting.","evidence_excerpt":"Proposal 3: Written Consent Proposal Amendment of the Company’s Certificate of Incorporation to allow stockholders to act by written consent. Adoption of the amendment required approval by the affirmative vote of at least a majority of the Company’s outstanding common stock. The Written Consent Proposal was approved by a vote of stockholders as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 3,694,592 1,531 0 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923117200/0001104659-23-117200-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-06"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}